Agios is a biopharmaceutical company that sells mitapivat and develops other medicines for rare diseases, mainly blood disorders. It last closed at $27.60 on Nov 20, down 4.03% on the day. The next earnings report for AGIO is expected around Thu, Feb 11, 2027. For the quarter ended Sep 2026, AGIO reported EPS of -$1.09 on revenue of $55.4M, with revenue up 330.0% from a year ago. Over its last 8 reports the stock moved an average of 5.0% the session after earnings. Over the last 12 months AGIO insiders bought $0 of stock on the open market and sold $4.9M, according to SEC Form 4 filings.
AI Auto Pilots
Is AGIO in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold AGIO.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on AGIOStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
AGIO · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 15% below its 20 day and 18% below its 50 day average. It is 16% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 35), near oversold. The nearest support is the swing low (Nov 5) at $27.57, and the nearest resistance the Pivot at $28.06.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 6.3%/day
Key levels
$44.0952 week high+59.7%
$33.99100 day average+23.2%
$32.6450 day average+18.3%
$31.89200 day average+15.5%
$31.8220 day average+15.3%
$29.39Swing high (Jun 5)+6.5%
$28.68Pivot R1+3.9%
$28.06Pivot+1.7%
$27.60Last close
$27.57Swing low (Nov 5)−0.1%
$26.97Pivot S1−2.3%
$23.0052 week low−16.7%
Indicators
RSI (14)
34.88
Weak, oversold below 30
Neutral
MACD
-1.21
Below its signal line
Bearish
Stochastic
20.9
Middle of its range
Neutral
ADX (14)
21.8
Weak trend
Williams %R
-97.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-109.3
Oversold below −100, overbought above 100
Oversold
Rate of change
−6.2%
Change over 10 sessions
Bearish
ATR (14)
$1.75
Typical daily range, 6.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 14.7%/day
Key levels
$44.0952 week high+59.7%
$33.99100 day average+23.2%
$32.6450 day average+18.3%
$31.89200 day average+15.5%
$31.8220 day average+15.3%
$29.39Swing high (Jun 5)+6.5%
$28.68Pivot R1+3.9%
$28.06Pivot+1.7%
$27.60Last close
$27.57Swing low (Nov 5)−0.1%
$26.97Pivot S1−2.3%
$23.0052 week low−16.7%
Indicators
RSI (14)
42.08
Middle of its range
Neutral
MACD
-0.55
Below its signal line
Bearish
Stochastic
18.1
Near the bottom of its range
Oversold
ADX (14)
12.2
No clear trend
Williams %R
-98.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-152.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−17.9%
Change over 10 sessions
Bearish
ATR (14)
$4.06
Typical daily range, 14.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for AGIO
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how AGIO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow AGIO usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for AGIOHow many large options trades hit AGIO, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in AGIO in the last 90 days.
From SEC Form 4 filings by AGIO's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AGIO is in one of them and how their past AGIO trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Agios Pharmaceuticals
Agios is a biopharmaceutical company that focuses on rare diseases, with a foundation in hematology, the study of blood disorders. Its lead medicine, mitapivat, is sold under the brand names AQVESME and PYRUKYND and is approved to treat anemia in adults with certain rare blood disorders. The company is also developing additional medicines for rare blood and metabolic conditions. Agios is based in Cambridge, Massachusetts, and serves patients and the clinicians who treat them.